Find Sodium Orinase manufacturers, exporters & distributors on PharmaCompass

PharmaCompass

Synopsis

Synopsis

ACTIVE PHARMA INGREDIENTS

0

API Suppliers

API Suppliers

0

USDMF

US DMFs Filed

0

CEP/COS

CEP/COS Certifications

0

JDMF

JDMFs Filed

0

EU WC

EU WC

0

KDMF

KDMF

0

NDC API

NDC API

0

VMF

NDC API

0

Listed Suppliers

Other Suppliers

API REF. PRICE (USD/KG)

$
$ 0

MARKET PLACE

0

API

0

FDF

0INTERMEDIATES

FINISHED DOSAGE FORMULATIONS

0

Europe

Europe

0

Canada

Canada

0

Australia

Australia

0

South Africa

South Africa

0

Listed Dossiers

Listed Dossiers

0 DRUGS IN DEVELOPMENT

FDF Dossiers

DRUG PRODUCT COMPOSITIONS

REF. STANDARDS OR IMPURITIES

0

EDQM

0

USP

0

JP

0

Others

PATENTS & EXCLUSIVITIES

0

US Patents

0

US Exclusivities

0

Health Canada Patents

DIGITAL CONTENT

0

Data Compilation #PharmaFlow

0

Stock Recap #PipelineProspector

0

Weekly News Recap #Phispers

0

News #PharmaBuzz

GLOBAL SALES INFORMATION

US Medicaid

NA

Annual Reports

NA

Finished Drug Prices

NA

0RELATED EXCIPIENT COMPANIES

0EXCIPIENTS BY APPLICATIONS

Chemistry

Click the arrow to open the dropdown
read-moreClick the button for full data set
Also known as: Tolbutamide sodium salt, 473-41-6, Sodium tolbutamide, Orinase diagnostic, Tolbutamide sodium, sterile, Tolbutamide sodium, sterile [usp]
Molecular Formula
C12H17N2NaO3S
Molecular Weight
292.33  g/mol
InChI Key
QKHDBRQBSNZFAK-UHFFFAOYSA-M
FDA UNII
E830VC49W5

Sodium Orinase
Tolbutamide Sodium is the sodium salt form of tolbutamide, a short-acting, first-generation sulfonylurea with hypoglycemic activity. Compared to second-generation sulfonylureas, tolbutamide is more likely to cause adverse effects, such as jaundice. This agent is rapidly metabolized by CYPC29.
1 2D Structure

Sodium Orinase

2 Identification
2.1 Computed Descriptors
2.1.1 IUPAC Name
sodium;butylcarbamoyl-(4-methylphenyl)sulfonylazanide
2.1.2 InChI
InChI=1S/C12H18N2O3S.Na/c1-3-4-9-13-12(15)14-18(16,17)11-7-5-10(2)6-8-11;/h5-8H,3-4,9H2,1-2H3,(H2,13,14,15);/q;+1/p-1
2.1.3 InChI Key
QKHDBRQBSNZFAK-UHFFFAOYSA-M
2.1.4 Canonical SMILES
CCCCNC(=O)[N-]S(=O)(=O)C1=CC=C(C=C1)C.[Na+]
2.2 Other Identifiers
2.2.1 UNII
E830VC49W5
2.3 Synonyms
2.3.1 Depositor-Supplied Synonyms

1. Tolbutamide Sodium Salt

2. 473-41-6

3. Sodium Tolbutamide

4. Orinase Diagnostic

5. Tolbutamide Sodium, Sterile

6. Tolbutamide Sodium, Sterile [usp]

7. E830vc49w5

8. Benzenesulfonamide, N-((butylamino)carbonyl)-4-methyl-, Monosodium Salt

9. Sodium;butylcarbamoyl-(4-methylphenyl)sulfonylazanide

10. Sodium Butamide

11. Sodium Orinase

12. Unii-e830vc49w5

13. 1-butyl-3-(p-tolylsulfonyl)urea Monosodium Salt

14. P-toluenosulfonylbutylomocznik, Sol Sodowa [polish]

15. P-toluenosulfonylbutylomocznik, Sol Sodowa

16. Orinase Diagnostic (tn)

17. Urea, 1-butyl-3-(p-tolylsulfonyl)-, Sodium Salt

18. Chembl1200874

19. Dtxsid50197090

20. Tolbutamide Sodium [vandf]

21. Tolbutamide Sodium [who-dd]

22. Tolbutamide Sodium Salt [mi]

23. Tolbutamide Sodium [orange Book]

24. D06177

25. Q27276989

26. 1-butyl-3-(p-tolylsulfonyl)urea, Monosodium Salt

27. Sodium;n'-butyl-n-(4-methylphenyl)sulfonylcarbamimidate

2.4 Create Date
2008-02-05
3 Chemical and Physical Properties
Molecular Weight 292.33 g/mol
Molecular Formula C12H17N2NaO3S
Hydrogen Bond Donor Count1
Hydrogen Bond Acceptor Count4
Rotatable Bond Count5
Exact Mass292.08575786 g/mol
Monoisotopic Mass292.08575786 g/mol
Topological Polar Surface Area72.6 Ų
Heavy Atom Count19
Formal Charge0
Complexity360
Isotope Atom Count0
Defined Atom Stereocenter Count0
Undefined Atom Stereocenter Count0
Defined Bond Stereocenter Count0
Undefined Bond Stereocenter Count0
Covalently Bonded Unit Count2

ABOUT THIS PAGE

Ask Us for Pharmaceutical Supplier and Partner
Ask Us, Find A Supplier / Partner
No Commissions, No Strings Attached, Get Connected for FREE

What are you looking for?

How can we help you?

The request can't be empty

Please read our Privacy Policy carefully

You must agree to the privacy policy

The name can't be empty
The company can't be empty.
The email can't be empty Please enter a valid email.
The mobile can't be empty